Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05998759 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 6, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contacts updated at 1 of 23 sitesv5
  2. Trial status: Not Yet Recruiting to Recruitingv4 Show 5 more changesShow less
    • Study sites: 22 to 23
    • Start date changed from estimate of Oct 2023 to Dec 2, 2023
    • Eligibility criteria shortened, about 10 words
    • Secondary endpoints: details revised at 1 of 8 entries
    • Collaborators: 21 to 22
  3. Start date: Aug 2023 to Oct 2023v3
  4. Eligibility criteria expanded, about 31 words
    • Secondary endpoints: details revised at 2 of 8 entries
    • Study description expanded, about 1 word
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to evaluate the efficacy and safety of Telitacicept for the treatment of connective tissue disease-associated thrombocytopenia.
Trial Details
NCT Number NCT05998759
Lead Sponsor Beijing Hospital
Collaborators: The First Affiliated Hospital of Anhui Medical University, The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial), Peking University People's Hospital, Peking University Third Hospital, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial People's Hospital, The First Affiliated Hospital of Zhengzhou University, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Second Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The Affiliated Hospital of Inner Mongolia Medical University, First Hospital of China Medical University, Shandong Provincial Hospital, Changhai Hospital, RenJi Hospital, Shanxi Bethune Hospital, West China Hospital, Institute of Hematology & Blood Diseases Hospital, China, Tianjin First Central Hospital, Tianjin Medical University General Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, The First People's Hospital of Yunnan
Conditions
(from sponsor)		 Connective Tissue Diseases, Thrombocytopenia
Related terms Connective Tissue Diseases, Thrombocytopenia
Enrollment 296 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov